LINC01399

Across TCGA pan-cancer cohorts, LINC01399 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated LINC01399 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC01399 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01399 expression acts as an unfavorable survival marker, although some lineages such as BRCA and READ show a favorable association.

ACC, BRCA, and KIRC are the cancer types where LINC01399 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	II,III,IV	0.172	0.581	<.001	81	view →
BRCA	DFS	Tertile	IV	0.991	0.571	.002	30	view →
KIRC	DFS	Quartile	IV	0.170	0.417	.016	24	view →
READ	DFS	Median	II,III,IV	0.840	0.514	.008	23	view →
LAML	DFS	Tertile	All	0.198	0.448	.029	18	view →
THYM	DFS	Median	III,IV	1.000	0.459	.007	16	view →
DLBC	DFS	Tertile	II,III,IV	0.217	0.918	.006	11	view →
ESCA	OS	Quartile	All	0.657	0.416	.023	8	view →
KIRP	DFS	Median	All	0.951	0.867	.011	7	view →
LUSC	DFS	Median	IV	0.134	0.827	.014	6	view →
KICH	DFS	Tertile	All	0.667	1.000	.018	5	view →
BLCA	DFS	Quartile	All	0.415	0.536	.037	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

LINC01399–ACC (DFS)

Open the ACC breakdown →